Small Molecules CDMO Services

Small Molecules CDMO Services

Products

Information

Porton Pharma is a global CDMO leader in small molecule APIs, offering efficient, flexible solutions throughout drug development—from pre-clinical to commercial production—for partners worldwide. With infrastructure exceeding 2200 m³, we support both early innovation and large-scale manufacturing. Having served over 1200 global customers and completed 4000+ milestone projects, we're a trusted pharmaceutical ally. Our services cover all API development phases, ensuring seamless integration from discovery to solid form selection. Whether non-GMP samples or GMP-compliant supply, Porton delivers precisely. Our adaptable FTE and FFS models meet unique project needs. Partner with us to expedite your small molecule therapeutics to market. Partner with Porton Pharma to accelerate your small molecule therapeutics from concept to market.
All Categories
API Contract ManufacturingCustom Manufacturing (general category)Chemistry, Manufacturing and Controls (CMC)
Main Categories
Biopharmaceutical ProductsContract Development and Manufacturing Organisations (CDMOs) and Contract Manufacturing Organisations (CMOs) (Services)
Porton Pharma Solutions Ltd.Porton Pharma Solutions is a global company with over 4,200 employees and R&D and GMP-compliant manufacturing facilities across the US, EU, and China. It provides customer-centric, innovative, and reliable CDMO solutions for Small Molecules, Tides, Biologics and Conjugates (such as ADCs, AOCs, PDCs, RDCs, etc.), as well as Advanced Therapy Medicinal Products, from pre-clinical to commercial stages.

Log in

See all the content and easy-to-use features by logging in or registering!